Link: Kang E
As research continues to unveil the intricate mechanisms of Methylene Blue and LDN, the future of personalized medicine shines bright
At Empower, this is the framework we operate in every day
Speaker: Mr Akis kalamaras (University of Thessaly, Volos, Greece) Lunch Break AESOP THEMATIC GROUPS (TG) EVENTS: NEW TECHNOLOGIES & PLANNING A0-07 (YTU Davutpasa Campus) A0-07 YTU Davutpasa Campus Convener: Michele Campagna (University of Cagliari) AESOP THEMATIC GROUPS (TG) EVENTS: OTHER TG's UPON REQUEST A1-05 A1-05 AESOP THEMATIC GROUPS (TG) EVENTS: PLANNING EDUCATION A0-04 (YTU Davutpasa Campus) A0-04 YTU Davutpasa Campus Convener: Andrea Frank (University of Birmingham) AESOP THEMATIC GROUPS (TG) EVENTS: PLANNING, LAW AND PROPERTY RIGHTS - PLPR A0-05 (YTU Davutpasa Campus) A0-05 YTU Davutpasa Campus AESOP THEMATIC GROUPS (TG) EVENTS: PUBLIC SPACES AND URBAN CULTURES (Brown Bag Lunch open to public) A0-06 (YTU Davutpasa Campus) A0-06 YTU Davutpasa Campus Convener: Tihomir Viderman (BTU Cottbus-Senftenberg) AESOP THEMATIC GROUPS (TG) EVENTS: RURAL PLANNING A0-03 (YTU Davutpasa Campus) A0-03 YTU Davutpasa Campus Convener: Menelaos Gkartzios (Newcastle University and Izmir Institute of Technology) JOURNAL: EUROPEAN PLANNING STUDIES (time to be confirmed) A1-03 A1-03 Convener: Dominic Stead (Aalto University) RT_29 CONVERSATIONS IN PLANNING THEORY AND PRACTICE: A COLLABORATIVE E-PUBLICATION BY AESOPS YOUNG ACADEMIC NETWORK A0-08 (YTU Davutpasa Campus) A0-08 YTU Davutpasa Campus Conveners: Francesca Dal Cin (CIAUD, Research Centre for Architecture, Urbanism and Design, Lisbon School of Architecture, Universidade de Lisboa), Mario Paris (Universit degli Studi di Bergamo - DISA) 564 CONVERSATIONS IN PLANNING THEORY AND PRACTICE: A COLLABORATIVE E-PUBLICATION BY AESOPS YOUNG ACADEMIC NETWORK The Conversations-in-Planning YA-AESOP booklet series, an initiative of AESOPs Young Academics (YA) network, foster meaningful dialogues between scholars on theories, concepts, ideas, and practices in spatial planning
Elsevier BV
Researchers need to source, reconstitute, and formulate peptides themselves, introducing variability that standardized pharmaceutical products avoid
